Saratov JOURNAL of Medical and Scientific Research

Early detection of cognitive impairment in patients with multiple sclerosis

Year: 2017, volume 13 Issue: в„–1 Pages: 164-168
Heading: Neurology Article type: Original article
Authors: Poverennova I.E., Romanova T.V., Zakharov A.V., Khivintseva E.V.
Organization: Samara State Medical University
Summary:

The aim of the study was to examine cognitive impairment in patients with multiple sclerosis with an emphasis on the speed and efficiency of information processing. It was supposed to reveal the patterns of these disorders depending on the duration and severity of the disease. Material and methods. The study included 50 patients with established diagnosis of clinically significant multiple sclerosis, a relapsing-remitting course. The EDSS score was evaluated. Cognitive functions were assessed using SDMT and PASAT-3 tests. All patients underwent a study of cognitive evoked potential. All examined patients were divided into 2 groups depending on the duration of the disease. Results. Cognitive screening tests PASSAT and SDMT showed no correlation with the duration of the disease severity and cannot serve as a tool for screening early signs of cognitive impairment in young patients with multiple sclerosis. A significant increase in latency of the P300 potential was obtained with increasing duration and severity of the disease, which correlates with the severity of cognitive dysfunction. Conclusion. This study is the initial step in the search for a tool for screening early manifestations of cognitive impairment in patients with multiple sclerosis. In the future it is planned to expand the research with the modernization of its design.

Bibliography:
1. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151
2. Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol 2011; 24: 244-249
3. Perez-Martin MY, et al. Cognitive status in patients with multiple sclerosis. Lanzarote Neuropsychiatr Dis Treat 2016; 12: 1553-1559. Published online 2016 Jun 30. Doi:10.2147/NDT.S105805
4. Ruet A, et al. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Neurology 2013; 80: 1501-1508
5. Hamalainen P, Rosti-Otajarvi E. Cognitive impairment in MS: rehabilitation approaches. Acta Neurol Scand 2016; 134 Suppl 200: 8-13
6. Zaharov AV, et al. Assessment of the risks of transformation of a monofocal clinically isolated syndrome into clinically significant multiple sclerosis. Zhurnal nevrologii i psikhiatrii imeni S. S. Korsakova 2013; (113): 28-31
7. Penner IK. Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions. Acta Neurol Scand 2016;134 Suppl 200: 19-23
8. Louapre C, etal. The association between intra-andjuxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2
mapping at 7T MRI. Neuroimage Clin 2016; 12: 879-886
9. Paul F. Pathology and MRI: exploring cognitive impairment in MS. Acta Neurol Scand 2016; 134 Suppl 200: 24-33
10. Banati M, et al. Social cognition and theory of mind in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 2010; 17(3): 426-433
11. Penner IK. Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions. Acta Neurol Scand 2016; 134 Suppl 200: 19-23
12. Habirov FA, et al The impact of comprehensive rehabilitation on social adaptation and quality of life in patients with multiple sclerosis. Zhurnal nevrologii i psikhiatrii imeni S. S. Korsakova 2009; (109): 138-141
13. Smith A. Symbol Digit Modalities Test. Los Angeles, CA: Western Psychological Services, 1982
14. Tombaugh TN. A comprehensive review of the paced auditory serial addition test (PASAT). Archives of Clinical Neuropsychology 2006; 21 (1): 53-76
15. Sundgren M, et al. P300 amplitude and response speed relate to preserved cognitive function in relapsing-remitting multiple sclerosis. Clin Neurophysiol 2015; 126 (4): 689-697.

AttachmentSize
2017_01-1_164-168.pdf292.07 KB

No votes yet